Gene-mapping study of extremes of cerebral small vessel disease reveals TRIM47 as a strong candidate
暂无分享,去创建一个
P. Matthews | M. Fornage | I. Deary | C. DeCarli | V. Gudnason | M. Bastin | B. Mazoyer | B. Psaty | D. Knopman | J. Rotter | H. Suzuki | M. Lathrop | P. Amouyel | C. V. van Duijn | C. Dufouil | C. Tzourio | H. Schmidt | J. Wardlaw | H. Grabe | A. Teumer | U. Völker | M. Vernooij | A. Beiser | M. V. Valdés Hernández | S. Muñoz Maniega | S. Harris | K. Wittfeld | J. Bis | X. Jian | M. Luciano | Jennifer A. Smith | Wei Zhao | L. Launer | S. Kardia | T. Mosley | S. Seshadri | D. Vojinović | T. Bartz | S. Weiss | T. Kacprowski | R. Bülow | A. Soumaré | Hieab H. H. Adams | C. Satizabal | W. Longstreth | S. Debette | A. Mishra | E. Hofer | Z. Morris | T. Couffinhal | C. Duplàa | M. Sargurupremraj | M. Ikram | A. Joutel | E. Tournier-Lasserve | R. Gottesman | M. Ihara | Shuo Li | Traci M Bartz | N. R. Zilhao | R. Schmidt | Yicheng Zhu | Miao Yu | Piyush G Gampawar | Sandra van der Auwera-Palitschka | Qiong Yang | O. Lopez | E. Boerwinkle | Hideaki Suzuki | Wei Zhao | C. V. van Duijn | B. Psaty | S. Kardia | M. A. Ikram | S. Harris | Nuno R Zilhao | H. Adams | Wei Zhao | P. Gampawar | Jennifer A. Smith
[1] V. Salomaa,et al. Genetic basis of lacunar stroke: a pooled analysis of individual patient data and genome-wide association studies , 2021, The Lancet Neurology.
[2] N. Eriksson,et al. Cerebral small vessel disease genomics and its implications across the lifespan , 2020, Nature Communications.
[3] C. Lewis,et al. Genome-wide association study of MRI markers of cerebral small vessel disease in 42,310 participants , 2020, Nature Communications.
[4] Ryan L. Collins,et al. The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.
[5] S. Robertson,et al. Biallelic variants in EFEMP1 in a man with a pronounced connective tissue phenotype , 2019, European Journal of Human Genetics.
[6] Selective RNA interference and gene silencing using reactive oxygen species-responsive lipid nanoparticles. , 2019, Chemical communications.
[7] M. Dichgans,et al. Small vessel disease: mechanisms and clinical implications , 2019, The Lancet Neurology.
[8] Tanya M. Teslovich,et al. Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls , 2019, Nature.
[9] Richard Frayne,et al. Quantifying blood-brain barrier leakage in small vessel disease: Review and consensus recommendations , 2019, Alzheimer's & Dementia.
[10] L. Beckett,et al. White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities , 2019, Alzheimer's & dementia.
[11] M. Fornage,et al. Association of variants in HTRA1 and NOTCH3 with MRI-defined extremes of cerebral small vessel disease in older subjects , 2019, Brain : a journal of neurology.
[12] C. Sudlow,et al. Genetic variation in PLEKHG1 is associated with white matter hyperintensities (n = 11,226) , 2019, Neurology.
[13] C. Sudlow,et al. Genetic and lifestyle risk factors for MRI-defined brain infarcts in a population-based setting , 2019, Neurology.
[14] P. Navas,et al. The mitochondrial phosphatase PPTC7 orchestrates mitochondrial metabolism regulating coenzyme Q10 biosynthesis. , 2018, Biochimica et biophysica acta. Bioenergetics.
[15] Yeting Zhang,et al. Functional equivalence of genome sequencing analysis pipelines enables harmonized variant calling across human genetics projects , 2018, Nature Communications.
[16] Koji Ando,et al. A molecular atlas of cell types and zonation in the brain vasculature , 2018, Nature.
[17] Bernard Mazoyer,et al. Burden of Dilated Perivascular Spaces, an Emerging Marker of Cerebral Small Vessel Disease, Is Highly Heritable , 2018, Stroke.
[18] Andrew D. Johnson,et al. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes , 2018, Nature Genetics.
[19] Feng Li,et al. The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis , 2018, Nature Medicine.
[20] N. Plesnila,et al. Cylindromatosis mediates neuronal cell death in vitro and in vivo , 2018, Cell Death & Differentiation.
[21] Evan Z. Macosko,et al. Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types , 2017, Nature Genetics.
[22] A. Mishra,et al. A Novel Approach for Pathway Analysis of GWAS Data Highlights Role of BMP Signaling and Muscle Cell Differentiation in Colorectal Cancer Susceptibility , 2017, Twin Research and Human Genetics.
[23] J. van der Grond,et al. Archetypal NOTCH3 mutations frequent in public exome: implications for CADASIL , 2016, Annals of clinical and translational neurology.
[24] P. Visscher,et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets , 2016, Nature Genetics.
[25] Anders Albrechtsen,et al. Weighting sequence variants based on their annotation increases power of whole-genome association studies , 2016, Nature Genetics.
[26] Xiaowei Zhan,et al. RVTESTS: an efficient and comprehensive tool for rare variant association analysis using sequence data , 2016, Bioinform..
[27] Kaitlin M. Fitzpatrick,et al. Genome-wide meta-analysis of cerebral white matter hyperintensities in patients with stroke , 2016, Neurology.
[28] M. Cohen-Salmon,et al. Purification of Mouse Brain Vessels. , 2015, Journal of visualized experiments : JoVE.
[29] Yakir A Reshef,et al. Partitioning heritability by functional annotation using genome-wide association summary statistics , 2015, Nature Genetics.
[30] Lorna M. Lopez,et al. Multiethnic Genome-Wide Association Study of Cerebral White Matter Hyperintensities on MRI , 2015, Circulation. Cardiovascular genetics.
[31] M. Daly,et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies , 2014, Nature Genetics.
[32] S. MacGregor,et al. VEGAS2: Software for More Flexible Gene-Based Testing , 2014, Twin Research and Human Genetics.
[33] Zoltán Kutalik,et al. Quality control and conduct of genome-wide association meta-analyses , 2014, Nature Protocols.
[34] Lisa J. Martin,et al. Meta-analysis of genome-wide association studies identifies 1q22 as a susceptibility locus for intracerebral hemorrhage. , 2014, American journal of human genetics.
[35] Nick C Fox,et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.
[36] Xihong Lin,et al. Optimal tests for rare variant effects in sequencing association studies. , 2012, Biostatistics.
[37] P. Visscher,et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits , 2012, Nature Genetics.
[38] Boer,et al. Genome-wide association studies of cerebral white matter lesion burden: the CHARGE Consortium , 2011 .
[39] Yun Li,et al. METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..
[40] P. Bork,et al. A method and server for predicting damaging missense mutations , 2010, Nature Methods.
[41] M. Fornage,et al. Genome-Wide Association Studies of MRI-Defined Brain Infarcts: Meta-Analysis From the CHARGE Consortium , 2010, Stroke.
[42] Renata C. Geer,et al. The NCBI BioSystems database , 2009, Nucleic Acids Res..
[43] Z. Wszolek,et al. VASCULAR RISK FACTORS AND DEMENTIA: HOW TO MOVE FORWARD? , 2009, Neurology.
[44] K. Lunetta,et al. Methods in Genetics and Clinical Interpretation Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium Design of Prospective Meta-Analyses of Genome-Wide Association Studies From 5 Cohorts , 2010 .
[45] Takako Sasaki,et al. Lack of fibulin-3 causes early aging and herniation, but not macular degeneration in mice. , 2007, Human molecular genetics.
[46] S. Greenberg,et al. Small vessels, big problems. , 2006, The New England journal of medicine.
[47] Charles DeCarli,et al. Genetic Variation in White Matter Hyperintensity Volume in the Framingham Study , 2004, Stroke.
[48] R. Holman,et al. Vascular Factors and Risk of Dementia: Design of the Three-City Study and Baseline Characteristics of the Study Population , 2003, Neuroepidemiology.
[49] A. Rao. Faculty Opinions recommendation of CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. , 2003 .
[50] G. Courtois,et al. The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination , 2003, Nature.
[51] S. Ebrahim,et al. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? , 2003, International journal of epidemiology.
[52] F. Baas,et al. GOA, a novel gene encoding a ring finger B-box coiled-coil protein, is overexpressed in astrocytoma. , 2001, Biochemical and biophysical research communications.
[53] K. Luo,et al. Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein. , 1999, Science.